These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15894067)

  • 21. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions.
    Pistis M; Perra S; Pillolla G; Melis M; Gessa GL; Muntoni AL
    Neuropharmacology; 2004 Jan; 46(1):115-25. PubMed ID: 14654103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids.
    Carriba P; Ortiz O; Patkar K; Justinova Z; Stroik J; Themann A; Müller C; Woods AS; Hope BT; Ciruela F; Casadó V; Canela EI; Lluis C; Goldberg SR; Moratalla R; Franco R; Ferré S
    Neuropsychopharmacology; 2007 Nov; 32(11):2249-59. PubMed ID: 17356572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoids alter recognition memory in rats.
    Kosiorek P; Hryniewicz A; Bialuk I; Zawadzka A; Winnicka MM
    Pol J Pharmacol; 2003; 55(5):903-10. PubMed ID: 14704485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135.
    Banister SD; Stuart J; Kevin RC; Edington A; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Hibbs DE; Glass M; Connor M; McGregor IS; Kassiou M
    ACS Chem Neurosci; 2015 Aug; 6(8):1445-58. PubMed ID: 25921407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent cyano and carboxamido side-chain analogues of 1', 1'-dimethyl-delta8-tetrahydrocannabinol.
    Singer M; Ryan WJ; Saha B; Martin BR; Razdan RK
    J Med Chem; 1998 Oct; 41(22):4400-7. PubMed ID: 9784115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats.
    McLaughlin PJ; Winston K; Swezey L; Wisniecki A; Aberman J; Tardif DJ; Betz AJ; Ishiwari K; Makriyannis A; Salamone JD
    Behav Pharmacol; 2003 Dec; 14(8):583-8. PubMed ID: 14665975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.
    Little PJ; Compton DR; Johnson MR; Melvin LS; Martin BR
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1046-51. PubMed ID: 2849657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical effects: learned behavior.
    Ferraro DP
    NIDA Res Monogr; 1977 Jul; (14):103-17. PubMed ID: 411038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats.
    McLaughlin PJ; Winston KM; Limebeer CL; Parker LA; Makriyannis A; Salamone JD
    Psychopharmacology (Berl); 2005 Jul; 180(2):286-93. PubMed ID: 15948012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A detailed characterization of the effects of four cannabinoid agonists on operant lever pressing.
    Carriero D; Aberman J; Lin SY; Hill A; Makriyannis A; Salamone JD
    Psychopharmacology (Berl); 1998 May; 137(2):147-56. PubMed ID: 9630001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of drugs on response duration differentiation. V: differential effects under temporal response differentiation schedules.
    McClure GY; Wenger GR; McMillan DE
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1357-67. PubMed ID: 9190872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: effects on food-reinforced behavior and comparisons with AM4113.
    Sink KS; Vemuri VK; Wood J; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2009 Jan; 91(3):303-6. PubMed ID: 18703081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The electrophysiological and behavioral evaluation of the peptide hemopressin and cannabinoid CB1 receptor agonist and antagonist in pentylenetetrazol model of epilepsy in rats.
    Al-Kaleel A; Aygun H; Al-Gailani L; Kabak Y; Inal S; Ayyildiz M; Him A; Agar E
    Pflugers Arch; 2023 Jun; 475(6):719-730. PubMed ID: 37100982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adamantyl cannabinoids: a novel class of cannabinergic ligands.
    Lu D; Meng Z; Thakur GA; Fan P; Steed J; Tartal CL; Hurst DP; Reggio PH; Deschamps JR; Parrish DA; George C; Järbe TU; Lamb RJ; Makriyannis A
    J Med Chem; 2005 Jul; 48(14):4576-85. PubMed ID: 15999995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioural and pharmacological characterization of a novel cannabinomimetic adamantane-derived indole, APICA, and considerations on the possible misuse as a psychotropic spice abuse, in C57bl/6J mice.
    Cannizzaro C; Malta G; Argo A; Brancato A; Roda G; Casagni E; Fumagalli L; Valoti E; Froldi R; Procaccianti P; Gambaro V
    Forensic Sci Int; 2016 Aug; 265():6-12. PubMed ID: 26826846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacological activity of the new adamantane derivative--potential antiparkinson preparation during subchronic administration].
    Val'dman EA
    Eksp Klin Farmakol; 2000; 63(5):3-6. PubMed ID: 11109514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists.
    Kiyoi T; Adam JM; Clark JK; Davies K; Easson AM; Edwards D; Feilden H; Fields R; Francis S; Jeremiah F; McArthur D; Morrison AJ; Prosser A; Ratcliffe PD; Schulz J; Wishart G; Baker J; Campbell R; Cottney JE; Deehan M; Epemolu O; Evans L
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1748-53. PubMed ID: 21316962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist.
    Luk T; Jin W; Zvonok A; Lu D; Lin XZ; Chavkin C; Makriyannis A; Mackie K
    Br J Pharmacol; 2004 Jun; 142(3):495-500. PubMed ID: 15148260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive effects of psychotomimetic drugs in rats discriminating number cues.
    Willmore CB; Krall DM; Spears FM; Makriyannis A; Elmer GI
    Psychopharmacology (Berl); 2009 Nov; 206(4):653-64. PubMed ID: 18843483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoid modulation of time estimation in the rat.
    Han CJ; Robinson JK
    Behav Neurosci; 2001 Feb; 115(1):243-6. PubMed ID: 11256448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.